SA

Saraswathi Amma Geethakumari Amma

Active Director Director DIN 10385903
DIN 10385903 First appointment Nov 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Saraswathi Amma Geethakumari Amma

Data last updated:

Saraswathi Amma Geethakumari Amma is a Director at Kapsel Medicines Private Limited (since 2023).

DIN 10385903
Primary Designation Director
First Appointment 08 Nov 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kapsel Medicines Private Limited U46497KL2023PTC084437
Director08 Nov 20232023Active

Board colleagues of Saraswathi Amma Geethakumari Amma

NameDINCompanyDesignation
Renukadevi Parukutty Amma10385902Kapsel Medicines Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kapsel Medicines Private Limited
Premium access

Shareholding and investment profile for Saraswathi Amma Geethakumari Amma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saraswathi Amma Geethakumari Amma

Saraswathi Amma Geethakumari Amma currently holds 1 directorship: Kapsel Medicines Private Limited (Director, since 08 Nov 2023).

Saraswathi Amma Geethakumari Amma was first appointed on 08 Nov 2023 as Director at Kapsel Medicines Private Limited.

The current boards of Saraswathi Amma Geethakumari Amma's companies include Renukadevi Parukutty Amma (Kapsel Medicines Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available